Logo image of MBLY

MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

NASDAQ:MBLY - Nasdaq - US60741F1049 - Common Stock

16.88  +0.21 (+1.26%)

Fundamental Rating

4

Taking everything into account, MBLY scores 4 out of 10 in our fundamental rating. MBLY was compared to 83 industry peers in the Automobile Components industry. While MBLY has a great health rating, there are worries on its profitability. MBLY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MBLY had positive earnings in the past year.
MBLY had a positive operating cash flow in the past year.
In the past 5 years MBLY always reported negative net income.
MBLY had a positive operating cash flow in each of the past 5 years.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 200M -200M 400M

1.2 Ratios

MBLY has a worse Return On Assets (-23.45%) than 91.57% of its industry peers.
MBLY has a worse Return On Equity (-24.47%) than 84.34% of its industry peers.
Industry RankSector Rank
ROA -23.45%
ROE -24.47%
ROIC N/A
ROA(3y)-0.38%
ROA(5y)N/A
ROE(3y)-0.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -0.2 -0.4 -0.6 -0.8 -1

1.3 Margins

With an excellent Gross Margin value of 46.86%, MBLY belongs to the best of the industry, outperforming 98.80% of the companies in the same industry.
MBLY's Gross Margin has improved in the last couple of years.
MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9%
GM growth 5YN/A
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MBLY has more shares outstanding
There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 15.33 indicates that MBLY is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 15.33, MBLY belongs to the best of the industry, outperforming 98.80% of the companies in the same industry.
There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.33
ROIC/WACCN/A
WACC9.11%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 5B 10B 15B

2.3 Liquidity

A Current Ratio of 5.80 indicates that MBLY has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.80, MBLY belongs to the best of the industry, outperforming 95.18% of the companies in the same industry.
A Quick Ratio of 4.54 indicates that MBLY has no problem at all paying its short term obligations.
MBLY has a Quick ratio of 4.54. This is amongst the best in the industry. MBLY outperforms 95.18% of its industry peers.
Industry RankSector Rank
Current Ratio 5.8
Quick Ratio 4.54
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

MBLY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.00%.
Looking at the last year, MBLY shows a very negative growth in Revenue. The Revenue has decreased by -10.26% in the last year.
MBLY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.07% yearly.
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
Revenue 1Y (TTM)-10.26%
Revenue growth 3Y29.07%
Revenue growth 5YN/A
Sales Q2Q%-8.3%

3.2 Future

MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.73% yearly.
MBLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.90% yearly.
EPS Next Y-71.2%
EPS Next 2Y-27.55%
EPS Next 3Y-8.51%
EPS Next 5Y20.73%
Revenue Next Year-20.83%
Revenue Next 2Y-3.04%
Revenue Next 3Y5.6%
Revenue Next 5Y17.9%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 42.20, MBLY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MBLY indicates a slightly more expensive valuation: MBLY is more expensive than 73.49% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, MBLY is valued a bit more expensive.
The Price/Forward Earnings ratio is 39.70, which means the current valuation is very expensive for MBLY.
74.70% of the companies in the same industry are cheaper than MBLY, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.44. MBLY is valued rather expensively when compared to this.
Industry RankSector Rank
PE 42.2
Fwd PE 39.7
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MBLY is valued expensively inside the industry as 85.54% of the companies are valued cheaper.
78.31% of the companies in the same industry are cheaper than MBLY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 63.97
EV/EBITDA 90.57
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as MBLY's earnings are expected to decrease with -8.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.55%
EPS Next 3Y-8.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MBLY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (1/22/2025, 10:49:04 AM)

16.88

+0.21 (+1.26%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)01-30 2025-01-30/amc
Inst Owners122.14%
Inst Owner Change-0.05%
Ins Owners3.33%
Ins Owner Change11.18%
Market Cap13.69B
Analysts72.12
Price Target20.71 (22.69%)
Short Float %19.05%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.22%
Min EPS beat(2)0.46%
Max EPS beat(2)17.98%
EPS beat(4)3
Avg EPS beat(4)2.88%
Min EPS beat(4)-8.52%
Max EPS beat(4)17.98%
EPS beat(8)7
Avg EPS beat(8)17.34%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.46%
Min Revenue beat(2)1.32%
Max Revenue beat(2)1.6%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-2.39%
Max Revenue beat(4)1.6%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.97%
PT rev (3m)-10.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-47.22%
EPS NY rev (1m)0%
EPS NY rev (3m)2.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-27.88%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 42.2
Fwd PE 39.7
P/S 7.6
P/FCF 63.97
P/OCF 44.89
P/B 1.13
P/tB 6.34
EV/EBITDA 90.57
EPS(TTM)0.4
EY2.37%
EPS(NY)0.43
Fwd EY2.52%
FCF(TTM)0.26
FCFY1.56%
OCF(TTM)0.38
OCFY2.23%
SpS2.22
BVpS14.89
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.45%
ROE -24.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.86%
FCFM 11.88%
ROA(3y)-0.38%
ROA(5y)N/A
ROE(3y)-0.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9%
GM growth 5YN/A
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 17.98%
Cap/Sales 5.05%
Interest Coverage N/A
Cash Conversion 225.93%
Profit Quality N/A
Current Ratio 5.8
Quick Ratio 4.54
Altman-Z 15.33
F-Score5
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)21.96%
Cap/Depr(5y)19.71%
Cap/Sales(3y)6.99%
Cap/Sales(5y)7.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
EPS Next Y-71.2%
EPS Next 2Y-27.55%
EPS Next 3Y-8.51%
EPS Next 5Y20.73%
Revenue 1Y (TTM)-10.26%
Revenue growth 3Y29.07%
Revenue growth 5YN/A
Sales Q2Q%-8.3%
Revenue Next Year-20.83%
Revenue Next 2Y-3.04%
Revenue Next 3Y5.6%
Revenue Next 5Y17.9%
EBIT growth 1Y-352.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-65.74%
EBIT Next 3Y-3.33%
EBIT Next 5Y17.07%
FCF growth 1Y-31.95%
FCF growth 3Y18.03%
FCF growth 5YN/A
OCF growth 1Y-27.84%
OCF growth 3Y13.29%
OCF growth 5YN/A